Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04315571 · ClinicalTrials.gov registry record · NA
Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents
A NA study of Ascites and Hypertension, Portal, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT04315571 is a NA study of Ascites and Hypertension, Portal that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 68 participants, below the 130-participant average among 6 other Ascites trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04315571, a NA study of Ascites and Hypertension, Portal, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
For this study, the investigators will be collecting data based on patients' random selection to two different approved standard of care treatments for ascites: Subjects will get randomized into either Group A: Large Volume Paracentesis (LVP) with albumin infusion, or Group B: an early transjugular intrahepatic portosystemic shunt (TIPS) procedure.
Conditions Studied
Interventions
- DEVICE Gore® Viatorr® Endoprosthesis with controlled expansion
- PROCEDURE Large Volume Paracentesis with albumin infusion
Study Locations (1)
California
- UCLA Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2020-03-24 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04315571
The ClinicalTrials.gov registry entry for NCT04315571 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 130-participant average among 6 other Ascites trials with a reported enrollment target (48% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ascites appearing as the primary indexed condition, and to 2 interventions - of which Gore® Viatorr® Endoprosthesis with controlled expansion is the first listed.
NCT04315571 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04315571 about?
NCT04315571 is a clinical study titled "Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents". For this study, the investigators will be collecting data based on patients' random selection to two different approved standard of care treatments for ascites: Subjects will get randomized into either Group A: Large Volume Paracentesis (LVP) with albumin infusion, or Group B: an early transjugular ...
What is the current status of trial NCT04315571?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2020-03-24. Estimated completion is 2027-04-01.
What conditions does trial NCT04315571 study?
This clinical trial studies the following conditions: Ascites, Hypertension, Portal.
What interventions are being tested in trial NCT04315571?
The interventions under investigation include: Gore® Viatorr® Endoprosthesis with controlled expansion (DEVICE), Large Volume Paracentesis with albumin infusion (PROCEDURE).
Who is sponsoring clinical trial NCT04315571?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04315571 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ascites
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites
COMPLETED · NA
-
High Dose Albumin in Refractory Ascites
RECRUITING · Phase 2
-
Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
COMPLETED · Phase 4
-
A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury
COMPLETED · Phase 2
-
Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
COMPLETED · Phase 3
-
Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.